Literature DB >> 25249697

Copeptin concentrations during psychological stress: the PsyCo study.

Judith Siegenthaler1, Carla Walti1, Sandrine Andrea Urwyler1, Philipp Schuetz1, Mirjam Christ-Crain2.   

Abstract

OBJECTIVE: The prognostic/diagnostic biomarker copeptin, an arginine vasopressin surrogate, reflects physical stress. Whether copeptin concentration increases upon psychological stress is unknown. We investigated psychological stress effects on copeptin secretion in healthy volunteers and patients with central diabetes insipidus (DI).
DESIGN: A prospective observational study was conducted to study the relation between copeptin concentration and psychological stress.
METHODS: A total of 20 healthy adults (ten female) and eight patients with central DI (four female) underwent the Trier Social Stress Test including, in order, 30-min waiting period, 10-min anticipation period, 10-min test period and 40-min recovery. Serum copeptin and cortisol concentrations and self-rated stress component feelings were determined in the pre-/post-anticipation period, post-test period and twice post-recovery.
RESULTS: In healthy volunteers, the median (25th-75th percentile) copeptin concentration peaked immediately during the post-test period at 5.1 (3.2-7.0) pmol/l, vs 3.7 (2.6-5.4) pmol/l at baseline. Over the measurement course, copeptin concentration significantly elevated (coefficient; 95% CI) (0.14; 0.06-0.23, P=0.002). The important predictors of increase in copeptin concentration were feelings of tension (0.06; 0.04-0.08, P<0.001) and avoidance (0.07; 0.04-0.10; P<0.001). Copeptin and cortisol levels were associated (0.43; 0.13-0.72, P<0.005). Patients with DI had lower baseline concentrations (1.55 (1.2-3.1) pmol/l) when compared with healthy volunteers, P=0.006. Patients with DI showed no increase upon psychological stress (peak 2.15 pmol/l (1.5-2.28), P=0.79). By contrast, cortisol values were similar in patients and volunteers.
CONCLUSIONS: In healthy volunteers, copeptin levels significantly increased after psychological stress testing; this response was blunted in patients with DI.
© 2014 European Society of Endocrinology.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25249697     DOI: 10.1530/EJE-14-0405

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  19 in total

Review 1.  Copeptin in the differential diagnosis of hypotonic polyuria.

Authors:  M Christ-Crain; W K Fenske
Journal:  J Endocrinol Invest       Date:  2019-07-31       Impact factor: 4.256

Review 2.  The role of copeptin in kidney disease.

Authors:  Pedro Iglesias; Ramona A Silvestre; María José Fernández-Reyes; Juan J Díez
Journal:  Endocrine       Date:  2022-10-15       Impact factor: 3.925

Review 3.  The Emerging Role of Copeptin.

Authors:  R Jalleh; D J Torpy
Journal:  Clin Biochem Rev       Date:  2021-02

4.  Copeptin Levels Before and After Transsphenoidal Surgery for Cushing Disease: A Potential Early Marker of Remission.

Authors:  Chelsi Flippo; Christina Tatsi; Ninet Sinaii; Maria De La Luz Sierra; Elena Belyavskaya; Charalampos Lyssikatos; Meg Keil; Elias Spanakis; Constantine A Stratakis
Journal:  J Endocr Soc       Date:  2022-04-06

Review 5.  Copeptin in the diagnosis of vasopressin-dependent disorders of fluid homeostasis.

Authors:  Mirjam Christ-Crain; Wiebke Fenske
Journal:  Nat Rev Endocrinol       Date:  2016-01-22       Impact factor: 43.330

6.  Association of HPA axis hormones with copeptin after psychological stress differs by sex.

Authors:  Elias K Spanakis; Gary S Wand; Nan Ji; Sherita Hill Golden
Journal:  Psychoneuroendocrinology       Date:  2015-10-17       Impact factor: 4.905

Review 7.  Vasopressin and Copeptin in health and disease.

Authors:  Mirjam Christ-Crain
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

8.  Empagliflozin Increases Short-Term Urinary Volume Output in Artificially Induced Syndrome of Inappropriate Antidiuresis.

Authors:  Julie Refardt; Bettina Winzeler; Fabian Meienberg; Deborah R Vogt; Mirjam Christ-Crain
Journal:  Int J Endocrinol       Date:  2017-12-20       Impact factor: 3.257

9.  Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study.

Authors:  Agorastos Agorastos; Anne Sommer; Alexandra Heinig; Klaus Wiedemann; Cüneyt Demiralay
Journal:  Front Psychiatry       Date:  2020-05-20       Impact factor: 4.157

10.  Copeptin under glucagon stimulation.

Authors:  Krzysztof C Lewandowski; Andrzej Lewiński; Elżbieta Skowrońska-Jóźwiak; Magdalena Stasiak; Wojciech Horzelski; Georg Brabant
Journal:  Endocrine       Date:  2015-11-17       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.